PTC299 for Treatment of Neurofibromatosis Type 2

Clinical trial NCT00911248 · TERMINATED

Trial details

NCT number: NCT00911248
Sponsor: PTC Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis 2

Start date: 2009-07-31
Primary completion: 2012-03-31
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.